Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard

Journal of the American Medical Informatics Association

Volumn 22, Issue 2, 2015, Pages 361-369

  Simpao, Allan F ^a   Ahumada, Luis M ^b   Desai, Bimal R ^a   Bonafide, Christopher P ^a   Gávez, Jorge A ^a   Rehman, Mohamed A ^a   Jawad, Abbas F ^a   Palma, Krisha L ^b   Shelov, Eric D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Clinical decision support systems; Drug interactions; Electronic health records; Medical order entry systems; Medication alert systems; Visual analytics

Indexed keywords

BENZODIAZEPINE;

ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; CROSS-SECTIONAL STUDY; DATA ANALYSIS SOFTWARE; DRUG INTERACTION; ELECTRONIC HEALTH RECORD; HUMAN; PEDIATRIC HOSPITAL; PHARMACIST; PHYSICIAN; PHYSICIAN ORDER ENTRY SYSTEM; PROCESS OPTIMIZATION; TOTAL QUALITY MANAGEMENT; AUDIOVISUAL AID; CHILD; COMPUTER ASSISTED DRUG THERAPY; COMPUTER INTERFACE; COMPUTER PROGRAM; DECISION SUPPORT SYSTEM; ELECTRONIC MEDICAL RECORD; EPIDEMIOLOGY; HOSPITAL; HOSPITAL INFORMATION SYSTEM; MEDICATION ERROR; PREVENTION AND CONTROL;

AUDIOVISUAL AIDS; CHILD; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG INTERACTIONS; DRUG THERAPY, COMPUTER-ASSISTED; HOSPITALS, PEDIATRIC; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; MEDICAL ORDER ENTRY SYSTEMS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICATION ERRORS; PHARMACISTS; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 84934288123     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2013-002538     Document Type: Article

References (25)

1. Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003;111:722-729.
2. Abramson EL, Kaushal R. Computerized provider order entry and patient safety. Pediatr Clin North Am 2012;59: 1247-1255.
3. Jha AK, Laguette J, Seger A, et al. Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Inform Assoc 2008;15:647-653.
4. Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163:2625-2631.
5. Phansalkar S, van der Sijs H, Tucker AD, et al. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. J Am Med Inform Assoc 2013;20:489-493.
6. Thomas JJ, Cook KA. A visual analytics agenda. IEEE Comput Graph Appl 2006;26:10-13.
7. Kimball R, Ross M, Thornthwaite W, Mundy J, Becker B. eds. The data warehouse lifecycle toolkit. 2nd edn. Hoboken, NJ: Wiley, 2008.
8. Tufte ER. The visual display of quantitative information. 2nd edn. Cheshire, CT: Graphics Press, 2001.
9. Shah VS, Weber RJ, Nahata MC. Contradictions in contraindications for drug-drug interactions. Ann Pharmacother 2011;45:409-411.
10. Medication Error Index. NCC MERP web site. http://www.nccmerp.org/medErrorCatIndex.html. Accessed July 20, 2014.
11. Chui KK, Wenger JB, Cohen SA, et al. Visual analytics for epidemiologists: understanding the interactions between age, time, and disease with multi-panel graphs. PLoS ONE 2011;6:e14683.
12. Kumasaka N, Nakamura Y, Kamatani N. The textile plot: a new linkage disequilibrium display of multiple-single nucleotide polymorphism genotype data. PLoS ONE 2010;5: e10207.
13. Naumova EN. Visual analytics for immunologists: data compression and fractal distributions. Self Nonself 2010;1: 241-249.
14. Resetar E, Reichley RM, Noirot LA, et al. Customizing a commercial rule base for detecting drug-drug interactions. AMIA Annu Symp Proc 2005:1094.
15. Kuperman GJ, Reichley RM, Bailey TC. Using commercial knowledge bases for clinical decision support: opportunities, hurdles, and recommendations. J Am Med Inform Assoc 2006;13:369-371.
16. Smithburger PL, Kane-Gill SL, Benedict NJ, et al. Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings. Ann Pharmacother 2010;44:1718-1724.
17. Taegtmeyer AB, Kullak-Ublick GA, Widmer N, et al. Clinical usefulness of electronic drug-drug interaction checking in the care of cardiovascular surgery inpatients. Cardiology 2012;123:219-222.
18. Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. J Am Med Inform Assoc 2004;11:104-112.
19. Smithburger PL, Buckley MS, Bejian S, et al. A critical evaluation of clinical decision support for the detection of drugdrug interactions. Expert Opin Drug Saf 2011;10:871-882.
20. Seidling HM, Phansalkar S, Seger DL, et al. Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support. J Am Med Inform Assoc 2011;18:479-484.
21. Phansalkar S, Desai AA, Bell D, et al. High-priority drugdrug interactions for use in electronic health records. J Am Med Inform Assoc 2012;19:735-743.
22. Harper MB, Longhurst CA, McGuire TL, et al. Children's Hospital Association CDS working group. Core drug-drug interaction alerts for inclusion in pediatric electronic health records with computerized prescriber order entry. J Patient Saf 2014;10:59-63.
23. Guzek M, Zorina OI, Semmler A, et al. Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System). Pharmacoepidemiol Drug Saf 2011;20: 930-938.
24. Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995;21: 541-548.
25. Statement from NCC MERP: Use of Medication Error Rates to Compare Health Care Organizations is of No Value. NCC MERP web site. http://www.nccmerp.org/council/council2002-06-11.html.Accessed July 20, 2014.